$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cyclooxygenase-2 and p53 Expression as Prognostic Indicators in Conventional Renal Cell Carcinoma 원문보기

Yonsei medical journal, v.46 no.1, 2005년, pp.133 - 140  

Cho, Dae Sung (Department of Urology, Ajou University School of Medicine, Suwon, Korea.) ,  Joo, Hee Jae (Department of Pathology, Ajou University School of Medicine, Suwon, Korea.) ,  Oh, Dong Keun (Department of Urology, Ajou University School of Medicine, Suwon, Korea.) ,  Kang, Ji Hun (Department of Urology, Ajou University School of Medicine, Suwon, Korea.) ,  Kim, Young Soo (Department of Urology, Ajou University School of Medicine, Suwon, Korea.) ,  Lee, Kyi Beom (Department of Pathology, Ajou University School of Medicine, Suwon, Korea.) ,  Kim, Se Joong (Department of Urology, Ajou University School of Medicine, Suwon, Korea.)

Abstract AI-Helper 아이콘AI-Helper

The aim of this study was to investigate the relationship of cyclooxygenase (COX)-2 and p53 expression with prognosis in patients with conventional renal cell carcinoma (RCC). Formalin-fixed, paraffin-embedded tissue sections of conventional RCC from 92 patients, who had undergone radical nephrectom...

주제어

참고문헌 (29)

  1. 1 Chow WH Devesa SS Warren JL Fraumeni JF Jr Rising incidence of renal cell cancer in the United States JAMA 1999 281 1628 1631 10235157 

  2. 2 Delahunt B Histopathologic prognostic indicators for renal cell carcinoma Semin Diagn Pathol 1998 15 68 76 9503507 

  3. 3 Yasunaga Y Shin M Miki T Okuyama A Aozasa K Prognostic factors of renal cell carcinoma: a multivariate analysis J Surg Oncol 1998 68 11 18 9610657 

  4. 4 Vane JR Bakhle YS Botting RM Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 1998 38 97 120 9597150 

  5. 5 Herschman HR Prostaglandin synthase 2 Biochim Biophys Acta 1996 1299 125 140 8555245 

  6. 6 Masunaga R Kohno H Dhar DK Ohno S Shibakita M Kinugasa S Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients Clin Cancer Res 2000 6 4064 4068 11051257 

  7. 7 Joo YE Rew JS Seo YH Choi SK Kim YJ Park CS Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer J Clin Gastroenterol 2003 37 28 33 12811205 

  8. 8 Denkert C Winzer KJ Müller BM Weichert W Pest S Köbel M Elevated expression of cyclooxgenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma Cancer 2003 97 2978 2987 12784332 

  9. 9 Chen YJ Wang LS Wang PH Lai CR Yen MS Ng HT High cyclooxygenase-2 expression in cervical adenocarcinomas Gynecol Oncol 2003 88 379 385 12648590 

  10. 10 Khuri FR Wu H Lee JJ Kemp BL Lotan R Lippman SM Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer Clin Cancer Res 2001 7 861 867 11309334 

  11. 11 Yoshimura R Sano H Masuda C Kawamura M Tsubouchi Y Chargui J Expression of cyclooxygenase-2 in prostate carcinoma Cancer 2000 89 589 596 10931458 

  12. 12 Shirahama T Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder Clin Cancer Res 2000 6 2424 2430 10873095 

  13. 13 Cao Y Prescott SM Many actions of cyclooxygenase-2 in cellular dynamics and in cancer J Cell Physiol 2002 190 279 286 11857443 

  14. 14 Williams CS Mann M DuBois RN The role of cyclooxygenases in inflammation, cancer, and development Oncogene 1999 18 7908 7916 10630643 

  15. 15 Pruthi RS Derksen E Gaston K Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review J Urol 2003 169 2352 2359 12771797 

  16. 16 Khan KN Stanfield KM Trajkovic D Knapp DW Expression of cyclooxygenase-2 in canine renal cell carcinoma Vet Pathol 2001 38 116 119 11199159 

  17. 17 Okamoto T Hara A Hino O Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model Cancer Sci 2003 94 22 25 12708469 

  18. 18 Miyata Y Koga S Kanda S Nishikido M Hayashi T Kanetake H Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival Clin Cancer Res 2003 9 1741 1749 12738729 

  19. 19 Yoshimura R Matsuyama M Kawahito Y Tsuchida K Kuratsukuri K Takemoto Y Study of cyclooxygenase-2 in renal cell carcinoma Int J Mol Med 2004 13 229 233 14719128 

  20. 20 Girgin C Tarhan H Hekimgil M Sezer A Gürel G p53 mutations and other prognostic factors of renal cell carcinoma Urol Int 2001 66 78 83 11223748 

  21. 21 Uchida T Gao JP Wang C Jiang SX Muramoto M Satoh T Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma Urology 2002 59 615 620 11927338 

  22. 22 Papadopoulos I Rudolph P Weichert-Jacobsen K Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma Eur Urol 1997 32 110 117 9266242 

  23. 23 Hofmockel G Wittmann A Dammrich J Bassukas ID Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance Anticancer Res 1996 16 3807 3811 9042262 

  24. 24 Guinan P Sobin LH Algaba F Badellino F Kameyama S MacLennan G TNM staging of renal cell carcinoma: Workgroup No. 3. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Cancer 1997 80 992 993 9307205 

  25. 25 Fuhrman SA Lasky LC Limas C Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 1982 6 655 663 7180965 

  26. 26 Sinicrope FA Ruan SB Cleary KR Stephens LC Lee JJ Levin B bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis Cancer Res 1995 55 237 241 7812951 

  27. 27 Hara S Kondo Y Matsuzawa I Hashimoto Y Kimura G Akimoto M Expression of cyclooxygenase-2 in human bladder and renal cell carcinoma Adv Exp Med Biol 2002 507 123 126 12664575 

  28. 28 Sheng H Shao J Morrow JD Beauchamp RD DuBois RN Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Res 1998 58 362 366 9443418 

  29. 29 Chan TA Morin PJ Vogelstein B Kinzler KW Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis Proc Natl Acad Sci USA 1998 95 681 686 9435252 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로